SCHEMBL29386972

SCHEMBL29386972

c1cnc2c(c1)C1(CCCC1)CN2

nearest known ligand 0.38

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MAP4K1 Q92918 3/20 0.38
CYP3A4 P08684 1/20 0.38
OTUD7B Q6GQQ9 1/20 0.38
CALCA P06881 2/20 0.33
CDC7 O00311 1/20 0.33
DBF4 Q9UBU7 1/20 0.33
SIGMAR1 Q99720 1/20 0.32
CYP1A2 P05177 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
MAPK1 P28482 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31
GRIN1 Q05586 1/20 0.30
GRIN2A Q12879 1/20 0.30
GRIN2B Q13224 1/20 0.30
GSK3B P49841 1/20 0.30
PDK2 Q15119 1/20 0.30
KCNH2 Q12809 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25275576 1.00 MAP4K1 (0.38) MAP4K1CYP3A4OTUD7BCALCACDC7
SCHEMBL26167986 0.96 MAP4K1 (0.38) MAP4K1CYP3A4OTUD7BCALCACDC7
SCHEMBL31456439 0.96 MAP4K1 (0.38) MAP4K1CYP3A4OTUD7BCALCACDC7
SCHEMBL31212132 0.92 OTUD7B (0.40) MAP4K1CYP3A4OTUD7BCALCACYP1A2
SCHEMBL18181144 0.92 OTUD7B (0.40) MAP4K1CYP3A4OTUD7BCALCACYP1A2
SCHEMBL6002104 0.86 ALDH1A1 (0.38) CYP3A4OTUD7BCYP1A2SMN1; SMN2MAPK1
SCHEMBL31456368 0.85 HTR2A (0.40) CYP3A4OTUD7BCYP1A2
SCHEMBL20066175 0.83 OTUD7B (0.40) MAP4K1CYP3A4OTUD7BCALCASIGMAR1
SCHEMBL29709345 0.83 OTUD7B (0.40) MAP4K1CYP3A4OTUD7BCALCASIGMAR1
SCHEMBL10152976 0.82 OTUD7B (0.42) OTUD7BCALCASIGMAR1NPSR1KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4192957-A2 TRPML MODULATORS Casma Therapeutics, Inc. (US) 2023-06-14 EP disclosed
CN-116113698-A TRPML modulators 卡斯玛治疗公司 2023-05-12 CN disclosed
WO-2022032073-A2 TRPML MODULATORS CASMA THERAPEUTICS, INC. (US) 2022-02-10 WO disclosed